Compounds > nafamostat

nafamostat and linezolid

nafamostat has been researched along with linezolid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Hara, Y; Hasegawa, D; Kato, Y; Komura, H; Kuriyama, N; Matsumoto, K; Morita, K; Nakamura, T; Nishida, O; Shimomura, Y; Yamashita, C1

Other Studies

2 other study(ies) available for nafamostat and linezolid

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Nafamostat mesilate inhibits linezolid metabolism via its antioxidant effects.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2020, Volume: 24, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Anticoagulants; Benzamidines; Guanidines; Linezolid; Mice; Mice, Inbred C57BL; Models, Animal

2020